Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rilonacept for Vascular Dysfunction in CKD
NCT01663103Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Aug 2012
- Primary completion
- Dec 2014
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of rilonacept in chronic kidney disease (CKD), sponsored by University of Colorado Denver. Started Aug 2012; status: completed.
02
Drugs
rilonacept
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01663103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01663103.